References
- Alexopoulos N, Katritsis D, Raggi P. Visceral adipose tissue as a source of inflammation and promoter of atherosclerosis. Atherosclerosis. 2014 Mar;233(1):104–112.
- Gustafson B. Adipose tissue, inflammation and atherosclerosis. J Atheroscler Thromb. 2010;17(4):332–341.
- Libby P. Inflammation in atherosclerosis. Nature. 2002 Dec 26;420(6917):868–874.
- Gradinaru D, Borsa C, Ionescu C, et al. Oxidized LDL and NO synthesis-biomarkers of endothelial dysfunction and ageing. Mech Ageing Dev. 2015Nov;151:101–113.
- Morishita R, Ishii J, Kusumi Y, et al. Association of serum oxidized lipoprotein(a) concentration with coronary artery disease: potential role of oxidized lipoprotein(a) in the vasucular wall. J Atheroscler Thromb. 2009;16(4):410–418.
- Zhao WW, Wu CH, Chen XP. Cryptotanshinone inhibits oxidized LDL-induced adhesion molecule expression via ROS dependent NF-B pathways. Cell Adhes Migr. 2016;10(3):248–258.
- Liao JK. Linking endothelial dysfunction with endothelial cell activation. J Clin Invest. 2013 Feb;123(2):540–541. .
- Gast KB, Den Heijer M, Smit JWA, et al. Individual contributions of visceral fat and total body fat to subclinical atherosclerosis: the NEO study. Atherosclerosis. 2015 Aug;241(2):547–554.
- Kranendonk ME, van Herwaarden JA, Stupkova T, et al. Inflammatory characteristics of distinct abdominal adipose tissue depots relate differently to metabolic risk factors for cardiovascular disease: distinct fat depots and vascular risk factors. Atherosclerosis. 2015 Apr;239(2):419–427.
- Kralova Lesna I, Kralova A, Cejkova S, et al. Characterisation and comparison of adipose tissue macrophages from human subcutaneous, visceral and perivascular adipose tissue. J Transl Med. 2016 Jul 11;14(1):208.
- Cifkova R, Skodova Z, Bruthans J, et al. Longitudinal trends in major cardiovascular risk factors in the Czech population between 1985 and 2007/8. Czech MONICA and Czech post-MONICA. Atherosclerosis. 2010 Aug;211(2):676–681. .
- Ait-Oufella H, Taleb S, Mallat Z, et al. Recent advances on the role of cytokines in atherosclerosis. Arterioscl Throm Vas. 2011 May;31(5):969–979.
- Lin JT, Kakkar V, Lu XJ. Impact of MCP-1 in atherosclerosis. Curr Pharm Design. 2014;20(28):4580–4588.
- Virani SS, Nambi V, Hoogeveen R, et al. Relationship between circulating levels of RANTES (regulated on activation, normal T-cell expressed, and secreted) and carotid plaque characteristics: the Atherosclerosis Risk in Communities (ARIC) carotid MRI study. Eur Heart J. 2011 Feb;32(4):459–468.
- Henrichot E, Juge-Aubry CE, Pernin AS, et al. Production of chemokines by perivascular adipose tissue - A role in the pathogenesis of atherosclerosis? Arterioscl Throm Vas. 2005 Dec;25(12):2594–2599.
- Hajer GR, van Haeften TW, Visseren FLJ. Adipose tissue dysfunction in obesity, diabetes, and vascular diseases. Eur Heart J. 2008 Dec;29(24):2959–2971. .
- Caer C, Rouault C, Le Roy T, et al. Immune cell-derived cytokines contribute to obesity-related inflammation, fibrogenesis and metabolic deregulation in human adipose tissue. Sci Rep-Uk. 2017 Jun 7;7. doi:10.1038/s41598-017-02660-w
- Braunersreuther V, Steffens S, Arnaud C, et al. A novel RANTES antagonist prevents progression of established atherosclerotic lesions in mice. Arterioscl Throm Vas. 2008 Jun;28(6):1090–1096.
- Dalmas E, Venteclef N, Caer C, et al. T cell-derived IL-22 amplifies IL-1 beta-driven inflammation in human adipose tissue: relevance to obesity and type 2 diabetes. Diabetes. 2014 Jun;63(6):1966–1977.
- Hivert MF, Sullivan LM, Fox CS, et al. Associations of adiponectin, resistin, and tumor necrosis factor-alpha with insulin resistance. J Clin Endocr Metab. 2008 Aug;93(8):3165–3172.
- Mtairag E, Chollet-Martin S, Oudghiri M, et al. Effects of interleukin-10 on monocyte/endothelial cell adhesion and MMP-9/TIMP-1 secretion. Cardiovasc Res. 2001 Mar;49(4):882–890.
- Verma SK, Garikipati VNS, Krishnamurthy P, et al. IL-10 accelerates re-endothelialization and inhibits post-injury intimal hyperplasia following carotid artery denudation. Plos One. 2016 25;11(1):Jan.
- Gimeno MJ, Pascual G, Garcia-Honduvilla N, et al. Modulatory role of IL10 in endothelial cell damage and platelet adhesion. Histol Histopathol. 2003 Jul;18(3):695–702.
- Galkina E, Ley K. Vascular adhesion molecules in atherosclerosis. Arterioscl Throm Vas. 2007 Nov;27(11):2292–2301.
- Sans M, Panes J, Ardite E, et al. VCAM-1 and ICAM-1 mediate leukocyte-endothelial cell adhesion in rat experimental colitis. Gastroenterology. 1999 Apr;116(4):874–883.
- Hung MJ, Cherng WJ, Hung MY, et al. Interleukin-6 inhibits endothelial nitric oxide synthase activation and increases endothelial nitric oxide synthase binding to stabilized caveolin-1 in human vascular endothelial cells. J Hypertens. 2010 May;28(5):940–951.
- Sena CM, Pereira AM, Seica R. Endothelial dysfunction - A major mediator of diabetic vascular disease. Bba-Mol Basis Dis. 2013 Dec;1832(12):2216–2231.
- Gamble JR, Khewgoodall Y, Vadas MA. Transforming growth-factor-beta inhibits E-selectin expression on human endothelial-cells. J Immunol. 1993 May 15;150(10):4494–4503.
- Walshe TE, Dole VS, Maharaj ASR, et al. Inhibition of VEGF or TGF-beta signaling activates endothelium and increases leukocyte rolling. Arterioscl Throm Vas. 2009 Aug;29(8):1185–U70. .
- Watson C, Whittaker S, Smith N, et al. IL-6 acts on endothelial cells to preferentially increase their adherence for lymphocytes. Clin Exp Immunol. 1996 Jul;105(1):112–119. .
- Bozic M, Alvarez A, de Pablo C, et al. Impaired vitamin D signaling in endothelial cell leads to an enhanced leukocyte-endothelium interplay: implications for atherosclerosis development. Plos One. 2015 Aug 31;10(8). DOI:10.1371/journal.pone.0136863
- Luckett-Chastain L, Calhoun K, Schartz T, et al. IL-6 influences the balance between M1 and M2 macrophages in a mouse model of irritant contact dermatitis. J Immunol. 2016 May 1;196:17.
- Kitagawa T, Yamamoto H, Hattori T, et al. Tumor necrosis factor-alpha gene expression in epicardial adipose tissue is related to coronary atherosclerosis assessed by computed tomography. J Atheroscler Thromb. 2018;25(3):269–280.
- Bing C. Is interleukin-1 beta a culprit in macrophage-adipocyte crosstalk in obesity? Adipocyte. 2015 Apr 3;4(2):149–152.
- Vicennati V, Vottero A, Friedman C, et al. Hormonal regulation of interleukin-6 production in human adipocytes. Int J Obesity. 2002 Jul;26(7):905–911.
- Sims JE, Smith DE. The IL-1 family: regulators of immunity. Nat Rev Immunol. 2010 Feb;10(2):89–102.
- Weisberg SP, McCann D, Desai M, et al. Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest. 2003 Dec;112(12):1796–1808.
- Kralova Lesna I, Petras M, Cejkova S, et al. Cardiovascular disease predictors and adipose tissue macrophage polarization: is there a link? Eur J Prev Cardiol. 2018 Feb;25(3):328–334.
- Cejkova S, Kralova Lesna I, Fronek J, et al. Pro-inflammatory gene expression in adipose tissue of patients with atherosclerosis. Physiol Res. 2017 Sep 22;66(4):633–640.
- Bae JS, Kim YU, Park MK, et al. Concentration dependent dual effect of thrombin in endothelial cells via Par-1 and Pi3 kinase. J Cell Physiol. 2009 Jun;219(3):744–751.
- Pfaffl MW. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 2001;29(9). DOI:10.1093/nar/29.9.e45.